Tango Therapeutics, Inc. Blueprint Medicines Corp (BPMC) insider trading activity
Tango Therapeutics, Inc. is Director of Blueprint Medicines Corp. Currently has a direct ownership of 3,400 shares of BPMC, which is worth approximately $321,742. The most recent transaction as insider was on Dec 08, 2021, when has been sold 3,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.4K
0%
3M change
0%
12M change
Total Value Held
$321,742
TTI
Tango Therapeutics, Inc.
Director
Cambridge, MA